Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asher

Showing results (351-360 of 6,822) with videos related to

Pageof 683
Sort By:
Nature Reviews. Drug Discovery|September 9, 2024
PPAR agonists provide new treatment options for inflammatory liver diseaseAsher Mullard
Nature Reviews. Drug Discovery|August 16, 2024
FDA approves IDH1 and IDH2 inhibitor for brain cancerAsher Mullard
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)|September 11, 1998
Children bewareJ Asher
Journal of the Tennessee Medical Association|August 1, 1971
"Trailing" phenomenon--a long lasting side effect of LSDH Asher
British Dental Journal|June 21, 1986
Neonatal care of infants with clefts of the lip and palate. Report of a WHO study tour to West Germany and ScandinaviaC Asher
Nature Reviews. Drug Discovery|November 3, 2021
Entasis antibiotic shows phase III promiseAsher Mullard
Nature Reviews. Drug Discovery|November 3, 2021
Novartis's canakinumab stumbles in cancer, againAsher Mullard
Nature Reviews. Drug Discovery|April 9, 2022
Engineered IL-2 cytokine takes pivotal immuno-oncology blowAsher Mullard
Nature Reviews. Drug Discovery|April 11, 2023
Pfizer bets big on ADCs with $43-billion Seagen acquisitionAsher Mullard
Nature Reviews. Drug Discovery|April 21, 2021
Long COVID's long R&D agendaAsher Mullard
Pageof 683

Showing results (351-360 of 6,822) with videos related to

Sort By:
Pageof 683
Nature Reviews. Drug Discovery|September 9, 2024
PPAR agonists provide new treatment options for inflammatory liver diseaseAsher Mullard
Nature Reviews. Drug Discovery|August 16, 2024
FDA approves IDH1 and IDH2 inhibitor for brain cancerAsher Mullard
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)|September 11, 1998
Children bewareJ Asher
Journal of the Tennessee Medical Association|August 1, 1971
"Trailing" phenomenon--a long lasting side effect of LSDH Asher
British Dental Journal|June 21, 1986
Neonatal care of infants with clefts of the lip and palate. Report of a WHO study tour to West Germany and ScandinaviaC Asher
Nature Reviews. Drug Discovery|November 3, 2021
Entasis antibiotic shows phase III promiseAsher Mullard
Nature Reviews. Drug Discovery|November 3, 2021
Novartis's canakinumab stumbles in cancer, againAsher Mullard
Nature Reviews. Drug Discovery|April 9, 2022
Engineered IL-2 cytokine takes pivotal immuno-oncology blowAsher Mullard
Nature Reviews. Drug Discovery|April 11, 2023
Pfizer bets big on ADCs with $43-billion Seagen acquisitionAsher Mullard
Nature Reviews. Drug Discovery|April 21, 2021
Long COVID's long R&D agendaAsher Mullard
Pageof 683